| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |